Project Details
Description
Protocol No. PTC124 GD 020 DMD entitled, A Phase 3 Efficacy and Safety Study of Ataluren in Patients with Nonsense Mutation Dystrophinopathy
| Status | Finished |
|---|---|
| Effective start/end date | 6/12/13 → 12/31/17 |
Funding
- PTC THERAPEUTICS, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.